Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

导出 OA

翻译打印收藏纠错

作者： Huishou,Fan ^[1] ; Bing,Wang ^[2] ; Lihui,Shi ^[3] ; Ni,Pan ^[4] ; Wenqiang,Yan ^[1] ; Jingyu,Xu ^[3] ; Lixin,Gong ^[4] ; Lingna,Li ^[1] ; Yuntong,Liu ^[3] ; Chenxing,Du ^[1] ; Jian,Cui ^[3] ; Guoqing,Zhu ^[1] ; Shuhui,Deng ^[3] ; Weiwei,Sui ^[1] ; Yan,Xu ^[3] ; Shuhua,Yi ^[1] ; Mu,Hao ^[3] ; Dehui,Zou ^[1] ; Xiequn,Chen ^[3] ; Lugui,Qiu ^[1] ; Gang,An ^[3]

作者单位： State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China. ^[1] Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. ^[2] Tianjin Institutes of Health Science, Tianjin, China. ^[3] Shanghai Kuaixu Biotechnology Co., Ltd., Shanghai, China. ^[4] Department of Hematology, Affiliated Hospital of Northwest University, Institute of Hematology, Northwest University, Xian, Shaanxi, China. ^[5]

主题词人类(Humans);多发性骨髓瘤(Multiple Myeloma);肿瘤, 残余(Neoplasm, Residual);预后(Prognosis);敏感性与特异性(Sensitivity and Specificity);流式细胞术(Flow Cytometry)

DOI 10.1158/1078-0432.CCR-23-2767

PMID 38170583

发布时间 2024-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交